在接受皮肤冠状动脉干预的患者中,高出血风险和出院后出血的相关性
Brenden S Ingraham1, Marco Valgimigli2, Dominick J Angiolillo3
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic proceedings
|February 5, 2025
概括
通过皮肤冠状动脉干预期间避免出血的策略至关重要. 基于患者出血和缺血风险的个性化抗血栓治疗是改善手术后结果的关键.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 药物治疗 药物治疗
背景情况:
- 在皮肤冠状动脉干预 (PCI) 中,避免出血至关重要.
- PCI复杂性和高风险患者群体已经抵消了减少出血并发症的收益.
- 在急性冠状动脉综合征中,积极的抗血小板治疗方案优先考虑缺血事件的减少,而不是出血风险.
研究的目的:
- 在PCI中审查当代和历史文献关于避免出血的策略.
- 提供在抗血栓治疗中导航复杂决策的策略.
- 根据患者特定的风险指导抗血栓治疗的个性化.
主要方法:
- 使用PubMed,EMBASE和Cochrane图书馆进行了全面的文献综述.
- 对手术技术和出院后药物治疗的分析.
- 评估出血和缺血风险因素.
主要成果:
- 程序技术和药物治疗的改进被高风险患者的PCI复杂性增加所抵消.
- 出院后出血的预后与缺血事件类似.
- 个性化风险评估对于优化抗血栓治疗至关重要.
结论:
- 通过识别个体出血和缺血风险来定制抗血栓治疗对于PCI后的结果至关重要.
- 对药物治疗的个性化方法可以最好地平衡减少缺血和出血事件.
- 本综述为在PCI患者中管理抗血栓治疗的临床医生提供了指导.
相关概念视频
Disorders of Hemostasis
688
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
688
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
Extrinsic and Intrinsic Pathways of Hemostasis
5.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.0K
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K


